Official Announcement of Physiological Diagnostic Criteria for Vascular Failure from the Japanese Society for Vascular Failure

Background: EndoPAT measurement has been reported to be well correlated with brachial artery flow-mediated vasodilatation (FMD) in coronary artery disease. However, this relation is still controversial in hypertensive patients or normal subjects and the pathophysiological mechanisms of EndoPAT index is still not completely clarified. Purpose: The purpose of this study is to investigate the correlation of EndoPAT index with FMD and the physiological role of EndoPAT index in hypertension. Methods: To study this aim, we simultaneously measured EndoPAT index (RHI) and FMD by forearm occlusion technique, that is reported to be nitric oxide (NO) dependent, in 47 hypertensive patients without hypertensive complication (62±11 years old). BaPWV and augmentation index (AI@75bpm) by EndoPAT were also measured at the same time. Results: RHI did not correlate with FMD nor baPWV (r= 0.17, NS) while FMD also did not correlate with baPWV (r=0.08, NS). However, baPWV significantly correlated with AI@75bpm by EndoPAT (r=0.50, p<0.01). In conclusion: Augmentation index expressed as AI@75bpm by EndoPAT was associated with arterial stiffness measured by baPWV. However, there is no correlation between EndoPAT index of RHI and FMD in hypertensive patients, suggesting that the indexes reflect partially different vascular functions.

[1]  K. Kario,et al.  Physiological Diagnostic Criteria for Vascular Failure. , 2018, Hypertension.

[2]  P. Mäntyselkä,et al.  Global arginine bioavailability ratio is decreased in patients with major depressive disorder. , 2018, Journal of affective disorders.

[3]  G. He,et al.  Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: A meta-analysis based on 4713 participants , 2016, European journal of preventive cardiology.

[4]  K. Kario,et al.  Why the radial augmentation index is low in patients with diabetes: The J-HOP study. , 2016, Atherosclerosis.

[5]  O. Wolkowitz,et al.  Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation , 2016, Brain, Behavior, and Immunity.

[6]  K. Kario,et al.  Effects of Celiprolol and Bisoprolol on Blood Pressure, Vascular Stiffness, and Baroreflex Sensitivity. , 2015, American journal of hypertension.

[7]  Daniel F. Freitag,et al.  Asymmetric Dimethylarginine and Cardiovascular Risk: Systematic Review and Meta-Analysis of 22 Prospective Studies , 2015, Journal of the American Heart Association.

[8]  S. Laurent,et al.  Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors. , 2014, European heart journal.

[9]  S. Kihara,et al.  The elderly. , 2014, Journal of atherosclerosis and thrombosis.

[10]  E. Lakatta,et al.  Hypertension Derivation and Validation of Diagnostic Thresholds for Central Blood Pressure Measurements Based on Long-Term Cardiovascular Risks , 2022 .

[11]  P. Segers,et al.  Central Pulse Pressure and Its Hemodynamic Determinants in Middle-Aged Adults With Impaired Fasting Glucose and Diabetes , 2013, Diabetes Care.

[12]  C. Jung,et al.  Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? , 2013, Cardiovascular research.

[13]  S. Momomura,et al.  Noninvasive estimation of central blood pressure and the augmentation index in the seated position: a validation study of two commercially available methods , 2013, Journal of hypertension.

[14]  S. Hazen,et al.  Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure. , 2013, Journal of cardiac failure.

[15]  R. Wolfe,et al.  Arginine de novo and nitric oxide production in disease states. , 2012, American journal of physiology. Endocrinology and metabolism.

[16]  T. Pieber,et al.  Multifactorial risk factor intervention in patients with Type 2 diabetes improves arginine bioavailability ratios , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[17]  James D. Thomas,et al.  Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1. , 2012, Journal of the American College of Cardiology.

[18]  T. Ninomiya,et al.  N-Terminal Pro-Brain Natriuretic Peptide and Risk of Cardiovascular Events in a Japanese Community: The Hisayama Study , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[19]  K. Kohara,et al.  Relatively lower central aortic pressure in patients with impaired insulin sensitivity and resistance: the Toon Health Study , 2011, Journal of hypertension.

[20]  W. März,et al.  Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography. , 2011, Atherosclerosis.

[21]  S. le Cessie,et al.  Asymmetric Dimethylarginine (ADMA) Levels Display a Morning Peak in Patients with Acute Myocardial Infarction , 2011, Disease markers.

[22]  Patrick Segers,et al.  Ethnic Differences in Arterial Wave Reflections and Normative Equations for Augmentation Index , 2011, Hypertension.

[23]  N. Girerd,et al.  N-Terminal Pro-Brain Natriuretic Peptide: A Powerful Predictor of Mortality in Hypertension , 2011, Hypertension.

[24]  J. Danesh,et al.  B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective Studies , 2009, Circulation.

[25]  Richard B Devereux,et al.  High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. , 2009, Journal of the American College of Cardiology.

[26]  Stanley L Hazen,et al.  Targeted Metabolomic Evaluation of Arginine Methylation and Cardiovascular Risks: Potential Mechanisms Beyond Nitric Oxide Synthase Inhibition , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[27]  S. Morris,et al.  Recent advances in arginine metabolism: roles and regulation of the arginases. , 2009, British journal of pharmacology.

[28]  S. Hazen,et al.  Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. , 2009, Journal of the American College of Cardiology.

[29]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  K. Teraoka,et al.  Synergistic effect of smoking and blood pressure on augmentation index in men, but not in women , 2009, Hypertension Research.

[31]  B. Westerhof,et al.  Different role of wave reflection magnitude and timing on left ventricular mass reduction during antihypertensive treatment , 2008, Journal of hypertension.

[32]  S. Hazen,et al.  Metabolic Profiling of Arginine and Nitric Oxide Pathways Predicts Hemodynamic Abnormalities and Mortality in Patients With Cardiogenic Shock After Acute Myocardial Infarction , 2007, Circulation.

[33]  C. Moinard,et al.  Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study , 2007, British Journal of Nutrition.

[34]  L. Ignarro,et al.  The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. , 2007, Pharmacology & therapeutics.

[35]  Kenji Takazawa,et al.  Relationship between Radial and Central Arterial Pulse Wave and Evaluation of Central Aortic Pressure Using the Radial Arterial Pulse Wave , 2007, Hypertension Research.

[36]  K. Node,et al.  Vascular failure: a new clinical entity for vascular disease , 2006, Journal of hypertension.

[37]  M. Sabatine,et al.  Inflammatory biomarkers in acute coronary syndromes: part II: acute-phase reactants and biomarkers of endothelial cell activation. , 2006, Circulation.

[38]  M. Sabatine,et al.  Inflammatory biomarkers in acute coronary syndromes: part I: introduction and cytokines. , 2006, Circulation.

[39]  D. Kass,et al.  L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. , 2006, JAMA.

[40]  A. Khoshdel,et al.  Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. , 2005, Journal of hypertension.

[41]  J. Horowitz,et al.  Determination of l-arginine and NG, NG - and NG, NG' -dimethyl-L-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[42]  J. Cooke.  Asymmetrical Dimethylarginine: The Über Marker? , 2004, Circulation.

[43]  J. Hochman,et al.  Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. , 2003, Circulation.

[44]  A. García-Méndez,et al.  Nitric oxide production by neutrophils obtained from patients during acute coronary syndromes: expression of the nitric oxide synthase isoforms. , 2002, Journal of the American College of Cardiology.

[45]  F. Ohsuzu,et al.  Morning attenuation of endothelium‐dependent, flow‐mediated dilation in healthy young men: Possible connection to morning peak of cardiac events? , 1999, Clinical cardiology.

[46]  J. Cooke,et al.  L-arginine and nitric oxide-related compounds in plasma: comparison of normal and arginine-free diets in a 24-h crossover study , 1999, Vascular medicine.

[47]  H. Hense,et al.  Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. , 1998, Journal of the American College of Cardiology.

[48]  Guoyao Wu,et al.  Arginine metabolism: nitric oxide and beyond. , 1998, The Biochemical journal.

[49]  J P Cooke,et al.  Nitric oxide synthase: role in the genesis of vascular disease. , 1997, Annual review of medicine.

[50]  G. Ciliberto,et al.  Elevated levels of interleukin-6 in unstable angina. , 1996, Circulation.

[51]  J. Hodgson,et al.  Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. , 1994, Journal of the American College of Cardiology.

[52]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[53]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[54]  J. Laragh,et al.  Standardization of M-mode echocardiographic left ventricular anatomic measurements. , 1984, Journal of the American College of Cardiology.

[55]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[56]  M. Litwin,et al.  Guidelines for the Management of Hypertension , 2015 .

[57]  G. Kimura,et al.  Distribution of central blood pressure values estimated by Omron HEM-9000AI in the Japanese general population , 2013, Hypertension Research.

[58]  J. Stockman.  Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell Disease , 2007 .

[59]  L. Bolognini,et al.  The radical cation of N,N-diethyl-para-phenylendiamine: A possible indicator of oxidative stress in biological samples , 2000 .

[60]  K. Shimada,et al.  Cross-sectional characterization of all classes of antihypertensives in terms of central blood pressure in Japanese hypertensive patients. , 2010, American journal of hypertension.